Omalizumab — Blue Cross Blue Shield Of Illinois
5 indications indexed for this drug.
- Chronic Rhinosinusitis With Nasal Polyps CrswnpView coverage criteria
- Chronic Spontaneous Urticaria Csu Chronic Idiopathic UrticarView coverage criteria
- Ige Mediated Food AllergyView coverage criteria
- Moderate To Severe Persistent AsthmaView coverage criteria
- Other Fda Labeled IndicationsView coverage criteria